These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37674084)

  • 21. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
    Riganti C; Castella B; Massaia M
    Front Immunol; 2018; 9():1246. PubMed ID: 29937767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
    Boutin L; Scotet E
    Front Immunol; 2018; 9():828. PubMed ID: 29731756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Activity Relationships of Butyrophilin 3 Ligands.
    Wiemer AJ
    ChemMedChem; 2020 Jun; 15(12):1030-1039. PubMed ID: 32453919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
    Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
    J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against
    Gay L; Mezouar S; Cano C; Foucher E; Gabriac M; Fullana M; Madakamutil L; Mège JL; Olive D
    Front Immunol; 2022; 13():915244. PubMed ID: 35833118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.
    Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T
    Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
    Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1.
    Nguyen K; Jin Y; Howell M; Hsiao CC; Wiemer AJ; Vinogradova O
    J Immunol; 2023 Jul; 211(1):23-33. PubMed ID: 37171180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
    Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
    Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of BTN3A1 on CD14
    Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BTN3A1-antibodies and phosphoantigens: TCRVγ9Vδ2 "see" the difference.
    Franchini DM; Michelas M; Lanvin O; Poupot M; Fournié JJ
    Eur J Immunol; 2017 Jun; 47(6):954-957. PubMed ID: 28597565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.
    Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M
    Front Immunol; 2018; 9():662. PubMed ID: 29670629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.
    Liu Y; Lui KS; Ye Z; Fung TY; Chen L; Sit PY; Leung CY; Mak NK; Wong KL; Lung HL; Tanaka Y; Cheung AKL
    Theranostics; 2023; 13(2):458-471. PubMed ID: 36632221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
    Uldrich AP; Rigau M; Godfrey DI
    Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Division of labor and cooperation between different butyrophilin proteins controls phosphoantigen-mediated activation of human γδ T cells.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Res Sq; 2023 Feb; ():. PubMed ID: 36824912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells.
    Herrmann T; Fichtner AS; Karunakaran MM
    Cells; 2020 Jun; 9(6):. PubMed ID: 32527033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells.
    Wang H; Henry O; Distefano MD; Wang YC; Räikkönen J; Mönkkönen J; Tanaka Y; Morita CT
    J Immunol; 2013 Aug; 191(3):1029-42. PubMed ID: 23833237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
    Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
    J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphoantigen recognition by Vγ9Vδ2 T cells.
    Herrmann T; Karunakaran MM
    Eur J Immunol; 2024 Nov; 54(11):e2451068. PubMed ID: 39148158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.